CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 546 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Dexamethasone 0.15 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01391793
NCT01391793Phase 3Completed
CompareCT.gov

Corticosteroids for Children With Febrile Urinary Tract Infections

Nader Shaikh·interventional·Posted Jul 12, 2011·Updated Jul 2, 2019

In Brief

A Phase 3 clinical trial evaluating Placebo and Dexamethasone for Acute Urinary Tract Infection and Urinary Tract Infection. Completed, enrolled 546 participants across 6 sites.

Detailed Summary

In this study the investigators will determine whether corticosteroids given at the time of urinary tract infection help prevent permanent damage to the kidneys.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Urinary Tract Infection, Urinary Tract Infection
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 12, 2011
Enrollment StartSep 1, 2011
Primary CompletionMar 30, 2018
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 15.0 years ago

Interventions

Placebodrug

Twice daily for 3 days

Dexamethasonedrug

0.15 mg/kg/dose twice daily for 3 days